9
项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的临床试验 / Unknown status临床1/2期IIT Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease. It is Self Funded (Patients' Own Funding) Clinical Trial
This is a Single arm, Single centre trial to check the safety and efficacy of bone marrow derived autologous mono nuclear cell(100 millions per dose )clinical trial to be conducted for 36 months in patients with optic nerve diseases.
/ Unknown status临床1/2期IIT A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism. It is Self Funded (Patients' Own Funding) Clinical Trial
This clinical trial is a single Arm, single centre to check the safety and efficacy of bone marrow derived autologous mono nuclear cells (MNC) (100 million per dose). Trial to be conducted for 36 months.
/ Unknown status临床1/2期IIT Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus. It is Self Funded (Patients' Own Funding) Clinical Trial
This study is Single arm, Single Centre trial to check the Safety and Efficacy of Bone Marrow Derived Autologous mono nuclear cells (100 Million per dose).trial to be conducted for 36 months in patients with diabetes Mellitus in India,Primary outcome measure are abolition or reduction of insulin by>50 percentage by the end of 6 months of ABMSCT-Any reduction in requirement of Insulin dosage and Improvement in HbA1C Level.
100 项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的临床结果
100 项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的转化医学
100 项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的专利（医药）
100 项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的药物交易
